Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

AAV-mediated gene transfer of scFvs shows viability for treatment of methamphetamine abuse in mice

Sep. 25, 2018

Gene therapy for cocaine addiction

Sep. 25, 2018

Treatment with the novel GPR88 agonist RTI-13951-33 reduces alcohol intake in vivo

Sep. 21, 2018

Amygdala Neurosciences announces SEARCH phase II studies with ANS-6637

Sep. 20, 2018

NIDA award supports Ensysce's development of opioid overdose protection platform

Sep. 19, 2018

NIAAA to conduct phase II study of ANS-6637 for alcohol use disorder

Sep. 13, 2018

Phoenix PharmaLabs receives support to study PPL-103 for cocaine addiction

Sep. 6, 2018

Lawrence Livermore National Laboratory develops nerve agent antidote LLNL-02

Aug. 27, 2018

Addicted to bile acids

Aug. 2, 2018

First cohort dosed in phase I study of OMS-527

July 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...